These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22325844)

  • 21. Treatment and prevention of tuberculosis in HIV-infected persons.
    Cohn DL
    Infect Dis Clin North Am; 1994 Jun; 8(2):399-412. PubMed ID: 8089467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.
    Manosuthi W; Tantanathip P; Chimsuntorn S; Eampokarap B; Thongyen S; Nilkamhang S; Sungkanuparph S
    Int J Infect Dis; 2010 Nov; 14(11):e1013-7. PubMed ID: 20880733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir.
    Zhang J; Zhu L; Stonier M; Coumbis J; Xu X; Wu Y; Arikan D; Farajallah A; Bertz R
    J Antimicrob Chemother; 2011 Sep; 66(9):2075-82. PubMed ID: 21712242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.
    Manosuthi W; Ruxrungtham K; Likanonsakul S; Prasithsirikul W; Inthong Y; Phoorisri T; Sungkanuparph S
    Clin Infect Dis; 2007 Jan; 44(1):141-4. PubMed ID: 17143831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV infection-related tuberculosis: clinical manifestations and treatment.
    Sterling TR; Pham PA; Chaisson RE
    Clin Infect Dis; 2010 May; 50 Suppl 3():S223-30. PubMed ID: 20397952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
    Marais BJ; Graham SM; Cotton MF; Beyers N
    J Infect Dis; 2007 Aug; 196 Suppl 1():S76-85. PubMed ID: 17624829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.
    Ifebunandu NA; Ukwaja KN; Obi SN
    Trop Doct; 2012 Apr; 42(2):74-6. PubMed ID: 22431822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].
    Erokhin VV; Kornilova ZKh; Alekseeva LP
    Probl Tuberk Bolezn Legk; 2005; (10):20-8. PubMed ID: 16318255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania.
    van den Broek J; Mfinanga S; Moshiro C; O'Brien R; Mugomela A; Lefi M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):547-52. PubMed ID: 9661820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?
    Kerkhoff AD; Wood R; Lawn SD
    AIDS; 2011 Apr; 25(7):1003-6. PubMed ID: 21346513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis.
    Boeree MJ; Sauvageot D; Banda HT; Harries AD; Zijlstra EE
    Trop Med Int Health; 2005 Aug; 10(8):723-33. PubMed ID: 16045458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6-9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan.
    Wang JY; Sun HY; Wang JT; Hung CC; Yu MC; Lee CH; Lee LN
    PLoS One; 2015; 10(12):e0144136. PubMed ID: 26633835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.
    Tansuphasawadikul S; Saito W; Kim J; Phonrat B; Dhitavat J; Chamnachanan S; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1053-60. PubMed ID: 18613546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.
    Ruan Q; Liu Q; Sun F; Shao L; Jin J; Yu S; Ai J; Zhang B; Zhang W
    Emerg Microbes Infect; 2016 Feb; 5(2):e12. PubMed ID: 26905025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries.
    Pettit AC; Jenkins CA; Blevins Peratikos M; Yotebieng M; Diero L; Do CD; Ross J; Veloso VG; Hawerlander D; Marcy O; Shepherd BE; Fenner L; Sterling TR;
    J Int AIDS Soc; 2019 Dec; 22(12):e25423. PubMed ID: 31814312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment.
    Hemanth Kumar AK; Narendran G; Kumar RS; Ramachandran G; Sekar L; Raja K; Swaminathan S
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):805-7. PubMed ID: 26056105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.